AURKB as a target in non-small cell lung cancer with acquired resistance to anti-EGFR therapy. - Bertran-Alamillo J; Cattan V; Schoumacher M; Codony-Servat J; Giménez-Capitán A; Cantero F; Burbridge M; Rodríguez S; Teixidó C; Roman R; Castellví J; García-Román S; et al. (Nature communications, 2019)